Cardiology - European Medical Journal

Continue

Cardiology

Filter
10 Mins
20 Oct 2020

The Evolution and Future Direction of The Cardiac Biomarker

The use of biomarkers has become routine in many areas of medicine. Knowing how and why these became incorporated into medical practice…
Cardiology CP
8 Mins
12 Oct 2020

High-Density Lipoproteins and Cardiovascular Disease

For >20 years, clinical trials have consistently demonstrated that the reduction of levels of low-density lipoprotein (LDL) cholesterol results in lower cardiovascular event rates, in both the primary and secondary prevention setting…
3 Mins
1 Oct 2020

COVID-19 and The Cardiovascular System

Despite the respiratory tract being the most affected system, many other organs may be involved in Covid-19, including the cardiovascular system
The Value of Intracardiac Echocardiography in Catheter Ablation of Cardiac Arrhythmias
8 Mins
18 Sep 2020

The Value of Intracardiac Echocardiography in Catheter Ablation of Cardiac Arrhythmias: Insights from Recent Clinical Studies

Catheter ablation is a well-established, safe, and effective treatment option for patients with atrial fibrillation (AF) and ventricular tachycardia (VT)…
Cardiology CP
4 Mins
7 Sep 2020

Prolonged Intraoperative Cardiac Arrest in a Young Patient with Successful Precordial Thump

Cardiac arrest during surgery is rare but is one of the most dreaded complications, particularly when there is no obvious underlying cause or risk…
EMJ Cardiology 8 [Supplement 2] 2020 Feature Image
9 Mins
14 Aug 2020

Worsening Heart Failure Events Despite Foundational Therapy in Patients with Heart Failure with Reduced Ejection Fraction: An Interview with International Cardiology Experts

HF is a global problem, with an estimated 63 million patients worldwide living with the disease.4 It is projected that the lifetime risk of developing…
6 Mins
10 Aug 2020

Cross-Sectional Study of Ethnicity and Chronic Heart Failure: Complex Interplay of Health and Wealth

Heart failure affects up to 26 million adults worldwide.1 The overall economic cost of heart failure in 2012 was estimated to be $108 billion per annum…
15 Mins
29 Jul 2020

Early Diagnosis and Treatment Initiation: Modern Patient Management in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

As leaders in the science of pulmonary arterial hypertension (PAH), Actelion (a Janssen Pharmaceutical Company of Johnson & Johnson) sponsored a key…